NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update
27 nov. 2024 07h01 HE
|
NurExone Biologic Inc
NurExone Reports Third Quarter 2024 Financial Results
and Provides Corporate Update
NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update
01 nov. 2024 16h50 HE
|
NurExone Biologic Inc
NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M
26 sept. 2024 16h03 HE
|
NurExone Biologic Inc
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
28 août 2024 08h34 HE
|
NurExone Biologic Inc
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
25 avr. 2024 08h35 HE
|
NurExone Biologic Inc
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence
15 mars 2024 16h05 HE
|
NurExone Biologic Inc
NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence
NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million
05 janv. 2024 08h30 HE
|
NurExone Biologic Inc
NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million